• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组胺在觉醒调节中的作用。

Histamine in the regulation of wakefulness.

机构信息

Neurology, University of Missouri, Harry S. Truman Memorial Veterans Hospital, Research, Room A023, 800 Hospital Drive, Columbia, MO 65210, USA.

出版信息

Sleep Med Rev. 2011 Feb;15(1):65-74. doi: 10.1016/j.smrv.2010.06.004. Epub 2010 Sep 20.

DOI:10.1016/j.smrv.2010.06.004
PMID:20851648
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3016451/
Abstract

The histaminergic system is exclusively localized within the posterior hypothalamus with projection to almost all the major regions of the central nervous system. Strong and consistent evidence exist to suggest that histamine, acting via H₁ and/or H₃ receptor has a pivotal role in the regulation of sleep-wakefulness. Administration of histamine or H₁ receptor agonists induces wakefulness, whereas administration of H₁ receptor antagonists promotes sleep. The H₃ receptor functions as an auto-receptor and regulates the synthesis and release of histamine. Activation of H₃ receptor reduces histamine release and promotes sleep. Conversely, blockade of H₃ receptor promotes wakefulness. Histamine release in the hypothalamus and other target regions is highest during wakefulness. The histaminergic neurons display maximal activity during the state of high vigilance, and cease their activity during non-rapid eye movement (NREM) and rapid eye movement (REM) sleep. The cerebrospinal levels of histamine are reduced in diseased states where hypersomnolence is a major symptom. The histamine deficient L-histidine decarboxylase knockout (HDC KO) mice display sleep fragmentation and increased REM sleep during the light period along with profound wakefulness deficit at dark onset, and in novel environment. Similar results have been obtained when histamine neurons are lesioned. These studies strongly implicate the histaminergic neurons of the TMN to play a critical role in the maintenance of high vigilance state during wakefulness.

摘要

组胺能系统仅局限于下丘脑后部,投射到中枢神经系统的几乎所有主要区域。有强有力且一致的证据表明,组胺通过 H₁ 和/或 H₃ 受体发挥作用,在调节睡眠-觉醒方面起着关键作用。给予组胺或 H₁ 受体激动剂可诱导觉醒,而给予 H₁ 受体拮抗剂则促进睡眠。H₃ 受体作为自受体,调节组胺的合成和释放。激活 H₃ 受体可减少组胺释放并促进睡眠。相反,阻断 H₃ 受体可促进觉醒。下丘脑和其他靶区的组胺释放在觉醒时最高。在高警觉状态下,组胺能神经元显示出最大的活性,并在非快速眼动(NREM)和快速眼动(REM)睡眠期间停止其活动。在以过度嗜睡为主要症状的疾病状态下,脑脊液中的组胺水平降低。缺乏组胺的 L-组氨酸脱羧酶敲除(HDC KO)小鼠在光照期间表现出睡眠片段化和 REM 睡眠增加,以及在黑暗开始时和新环境中严重的觉醒缺陷。当组胺神经元被损伤时,也得到了类似的结果。这些研究强烈表明 TMN 的组胺能神经元在维持觉醒时的高警觉状态中起着关键作用。

相似文献

1
Histamine in the regulation of wakefulness.组胺在觉醒调节中的作用。
Sleep Med Rev. 2011 Feb;15(1):65-74. doi: 10.1016/j.smrv.2010.06.004. Epub 2010 Sep 20.
2
Histamine-1 receptor is not required as a downstream effector of orexin-2 receptor in maintenance of basal sleep/wake states.组胺 1 受体不是维持基础睡眠/觉醒状态的食欲素 2 受体的下游效应物。
Acta Physiol (Oxf). 2010 Mar;198(3):287-94. doi: 10.1111/j.1748-1716.2009.02032.x. Epub 2009 Aug 20.
3
Altered sleep-wake characteristics and lack of arousal response to H3 receptor antagonist in histamine H1 receptor knockout mice.组胺H1受体基因敲除小鼠的睡眠-觉醒特征改变及对H3受体拮抗剂缺乏唤醒反应
Proc Natl Acad Sci U S A. 2006 Mar 21;103(12):4687-92. doi: 10.1073/pnas.0600451103. Epub 2006 Mar 13.
4
The brain H3-receptor as a novel therapeutic target for vigilance and sleep-wake disorders.大脑H3受体作为警觉和睡眠-觉醒障碍的新型治疗靶点。
Biochem Pharmacol. 2007 Apr 15;73(8):1157-71. doi: 10.1016/j.bcp.2007.01.002. Epub 2007 Jan 7.
5
Role of histamine H1-receptor on behavioral states and wake maintenance during deficiency of a brain activating system: A study using a knockout mouse model.组胺H1受体在脑激活系统缺乏时对行为状态和觉醒维持的作用:一项使用基因敲除小鼠模型的研究
Neuropharmacology. 2016 Jul;106:20-34. doi: 10.1016/j.neuropharm.2015.12.014. Epub 2015 Dec 23.
6
Arousal effect of orexin A depends on activation of the histaminergic system.食欲素A的觉醒效应取决于组胺能系统的激活。
Proc Natl Acad Sci U S A. 2001 Aug 14;98(17):9965-70. doi: 10.1073/pnas.181330998. Epub 2001 Aug 7.
7
[Regulation of the phases of the sleep-wakefulness cycle with histamine].[组胺对睡眠-觉醒周期各阶段的调节作用]
Rev Neurol. 2017 Mar 16;64(6):267-277.
8
Participation of histaminergic H1 and noradrenergic alpha 1 receptors in orexin A-induced wakefulness in rats.组胺能H1受体和去甲肾上腺素能α1受体参与大鼠中食欲素A诱导的觉醒。
Brain Res. 2004 Oct 8;1023(1):121-5. doi: 10.1016/j.brainres.2004.07.031.
9
Adenosine in the tuberomammillary nucleus inhibits the histaminergic system via A1 receptors and promotes non-rapid eye movement sleep.结节乳头体核中的腺苷通过A1受体抑制组胺能系统,并促进非快速眼动睡眠。
Proc Natl Acad Sci U S A. 2008 Dec 16;105(50):19992-7. doi: 10.1073/pnas.0810926105. Epub 2008 Dec 9.
10
Anatomical, physiological, and pharmacological characteristics of histidine decarboxylase knock-out mice: evidence for the role of brain histamine in behavioral and sleep-wake control.组氨酸脱羧酶基因敲除小鼠的解剖学、生理学和药理学特征:脑组胺在行为及睡眠-觉醒控制中作用的证据
J Neurosci. 2002 Sep 1;22(17):7695-711. doi: 10.1523/JNEUROSCI.22-17-07695.2002.

引用本文的文献

1
Investigation of the Binding Characteristics of Agonists and Various Antagonists Targeting Histamine 1 Receptor.组胺1受体激动剂和各类拮抗剂结合特性的研究
Pharm Res. 2025 Aug;42(8):1315-1329. doi: 10.1007/s11095-025-03899-z. Epub 2025 Aug 4.
2
Efficacy and Safety of Histamine H3 Receptor Antagonist/Inverse Agonist Including Betahistine for Schizophrenia: A Systematic Review and Meta-Analysis.包括倍他司汀在内的组胺H3受体拮抗剂/反向激动剂治疗精神分裂症的疗效与安全性:一项系统评价和荟萃分析
Neuropsychopharmacol Rep. 2025 Sep;45(3):e70034. doi: 10.1002/npr2.70034.
3
High-fat diet-induced osteoporosis in mice under hypoxic conditions.低氧条件下高脂饮食诱导的小鼠骨质疏松症
BMC Musculoskelet Disord. 2025 May 16;26(1):487. doi: 10.1186/s12891-025-08725-6.
4
Integrative sleep management: from molecular pathways to conventional and herbal treatments.综合睡眠管理:从分子途径到传统与草药治疗
Naunyn Schmiedebergs Arch Pharmacol. 2025 May 8. doi: 10.1007/s00210-025-04183-y.
5
The effect of doxepin 3 mg on sleep latency: a pooled analysis of two phase 3 trials.3毫克多塞平对睡眠潜伏期的影响:两项3期试验的汇总分析。
Sleep Breath. 2025 Apr 14;29(2):158. doi: 10.1007/s11325-025-03328-w.
6
HDC downregulation induced by chronic stress promotes ovarian cancer progression via the IL-6/STAT3/S100A9 pathway.慢性应激诱导的组氨酸脱羧酶下调通过IL-6/STAT3/S100A9途径促进卵巢癌进展。
Front Pharmacol. 2024 Dec 10;15:1485885. doi: 10.3389/fphar.2024.1485885. eCollection 2024.
7
The Utility of Betahistine Dihydrochloride, a Structural Analog of Histamine, in Clozapine-associated Daytime Sedation: A Case Series.组胺结构类似物盐酸倍他司汀在氯氮平相关日间镇静中的应用:病例系列
Indian J Psychol Med. 2024 Jan 31:02537176241226902. doi: 10.1177/02537176241226902.
8
Prevalence of Diamine Oxidase Enzyme (DAO) Deficiency in Subjects with Insomnia-Related Symptoms.患有失眠相关症状的受试者中二胺氧化酶(DAO)缺乏症的患病率。
J Clin Med. 2024 Aug 6;13(16):4583. doi: 10.3390/jcm13164583.
9
Microstructural changes in the inferior tuberal hypothalamus correlate with daytime sleepiness in Lewy body disease.路易体病中下丘脑结节下部的微观结构变化与日间嗜睡相关。
medRxiv. 2024 Aug 16:2024.08.16.24312102. doi: 10.1101/2024.08.16.24312102.
10
Pharmacometabolomics and mass spectrometry imaging approach to reveal the neurochemical mechanisms of .药物代谢组学与质谱成像方法揭示……的神经化学机制
J Pharm Anal. 2024 Jul;14(7):100973. doi: 10.1016/j.jpha.2024.100973. Epub 2024 Mar 28.

本文引用的文献

1
The role of dorsal raphe nucleus serotonergic and non-serotonergic neurons, and of their receptors, in regulating waking and rapid eye movement (REM) sleep.中缝背核 5-羟色胺能和非 5-羟色胺能神经元及其受体在调节觉醒和快速眼动(REM)睡眠中的作用。
Sleep Med Rev. 2010 Oct;14(5):319-27. doi: 10.1016/j.smrv.2009.10.003. Epub 2010 Feb 12.
2
Orexin/hypocretin and histamine: distinct roles in the control of wakefulness demonstrated using knock-out mouse models.食欲素/下丘脑泌素与组胺:利用基因敲除小鼠模型证明它们在清醒控制中的不同作用。
J Neurosci. 2009 Nov 18;29(46):14423-38. doi: 10.1523/JNEUROSCI.2604-09.2009.
3
Differential effects of acute and repeat dosing with the H3 antagonist GSK189254 on the sleep-wake cycle and narcoleptic episodes in Ox-/- mice.H3拮抗剂GSK189254急性给药和重复给药对Ox-/-小鼠睡眠-觉醒周期及发作性睡病发作的不同影响。
Br J Pharmacol. 2009 May;157(1):104-17. doi: 10.1111/j.1476-5381.2009.00205.x.
4
The histamine H4 receptor is functionally expressed on neurons in the mammalian CNS.组胺H4受体在哺乳动物中枢神经系统的神经元上有功能性表达。
Br J Pharmacol. 2009 May;157(1):55-63. doi: 10.1111/j.1476-5381.2009.00227.x.
5
CSF histamine contents in narcolepsy, idiopathic hypersomnia and obstructive sleep apnea syndrome.发作性睡病、特发性睡眠增多症和阻塞性睡眠呼吸暂停综合征患者脑脊液中的组胺含量
Sleep. 2009 Feb;32(2):181-7. doi: 10.1093/sleep/32.2.181.
6
Decreased CSF histamine in narcolepsy with and without low CSF hypocretin-1 in comparison to healthy controls.与健康对照组相比,伴或不伴脑脊液中低食欲素-1的发作性睡病患者脑脊液中组胺减少。
Sleep. 2009 Feb;32(2):175-80. doi: 10.1093/sleep/32.2.175.
7
Is low histamine a fundamental cause of sleepiness in narcolepsy and idiopathic hypersomnia?低组胺是发作性睡病和特发性嗜睡症中嗜睡的根本原因吗?
Sleep. 2009 Feb;32(2):133-4. doi: 10.1093/sleep/32.2.133.
8
Effects of histamine H1-antagonists on sleep-awake state in rats placed on a grid suspended over water or on sawdust.组胺H1拮抗剂对置于水面上方网格或锯末上的大鼠睡眠-觉醒状态的影响。
Biol Pharm Bull. 2009 Jan;32(1):51-4. doi: 10.1248/bpb.32.51.
9
Adenosine in the tuberomammillary nucleus inhibits the histaminergic system via A1 receptors and promotes non-rapid eye movement sleep.结节乳头体核中的腺苷通过A1受体抑制组胺能系统,并促进非快速眼动睡眠。
Proc Natl Acad Sci U S A. 2008 Dec 16;105(50):19992-7. doi: 10.1073/pnas.0810926105. Epub 2008 Dec 9.
10
Histamine H3 receptor antagonists go to clinics.组胺H3受体拮抗剂进入临床应用。
Biol Pharm Bull. 2008 Dec;31(12):2163-81. doi: 10.1248/bpb.31.2163.